Literature DB >> 10582600

Dopamine neuronal transport kinetics and effects of amphetamine.

S R Jones1, J D Joseph, L S Barak, M G Caron, R M Wightman.   

Abstract

The dopamine (DA) transporter (DAT) regulates DA neurotransmission by recycling DA back into neurons. Drugs that interfere with DAT function, e.g., cocaine and amphetamine, can have profound behavioral effects. The kinetics of DA transport by DAT in isolated synaptosomal or single cell preparations have been previously studied. To investigate how DA transport is regulated in intact tissue and to examine how amphetamine affects the DAT, the kinetics of DA uptake by the DAT were examined in tissue slices of the mouse caudate-putamen with fast-scan cyclic voltammetry. The data demonstrate that inward DA transport is saturable and sodium-dependent. Elevated levels of cytoplasmic DA resulting from disruption of vesicular storage by incubation with 10 microM Ro 4-1284 did not generate DA efflux or decrease its uptake rate. However, incubation with 10 microM amphetamine reduced the net DA uptake rate and increased extracellular DA levels due to DA efflux through the DAT. In addition, a new, elevated steady-state level of extracellular DA was established after electrically stimulated DA release in the presence of amphetamine, norepinephrine, and exogenous DA. These results from intact tissue are consistent with a kinetic model of the DAT established in more purified preparations in which amphetamine and other transported substances make the inwardly facing DAT available for outward transport of intracellular DA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582600     DOI: 10.1046/j.1471-4159.1999.0732406.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  44 in total

1.  Ex Vivo Measurement of Electrically Evoked Dopamine Release in Zebrafish Whole Brain.

Authors:  Mimi Shin; Thomas M Field; Chase S Stucky; Mia N Furgurson; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2017-06-28       Impact factor: 4.418

2.  MSI-1436 reduces acute food intake without affecting dopamine transporter activity.

Authors:  Mitchell F Roitman; Seth Wescott; Jackson J Cone; Michael P McLane; Henry R Wolfe
Journal:  Pharmacol Biochem Behav       Date:  2010-05-15       Impact factor: 3.533

3.  Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Authors:  Amy R Johnson; Matthew L Banks; Dana E Selley; S Stevens Negus
Journal:  Neuropsychopharmacology       Date:  2018-04-19       Impact factor: 7.853

4.  Modulating dopamine release by optogenetics in transgenic mice reveals terminal dopaminergic dynamics.

Authors:  Yao Lu; Nicolette Driscoll; Ilker Ozden; Zeyang Yu; Arto V Nurmikko
Journal:  Neurophotonics       Date:  2015-07-09       Impact factor: 3.593

5.  Amphetamine potency varies with dopamine uptake rate across striatal subregions.

Authors:  Cody A Siciliano; Erin S Calipari; Sara R Jones
Journal:  J Neurochem       Date:  2014-07-30       Impact factor: 5.372

6.  Amphetamine Dose-Dependently Decreases and Increases Binge Intake of Fat and Sucrose Independent of Sex.

Authors:  Katherine Stuhrman West; Valen Lawson; Andrew M Swanson; Anna I Dunigan; Aaron G Roseberry
Journal:  Obesity (Silver Spring)       Date:  2019-09-27       Impact factor: 5.002

7.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

8.  Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry.

Authors:  Alexander F Hoffman; Charles E Spivak; Carl R Lupica
Journal:  ACS Chem Neurosci       Date:  2016-03-28       Impact factor: 4.418

9.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

10.  Individual variation in incentive salience attribution and accumbens dopamine transporter expression and function.

Authors:  Bryan F Singer; Bipasha Guptaroy; Curtis J Austin; Isabella Wohl; Vedran Lovic; Jillian L Seiler; Roxanne A Vaughan; Margaret E Gnegy; Terry E Robinson; Brandon J Aragona
Journal:  Eur J Neurosci       Date:  2016-01-07       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.